| Metric | FY 2025 | Prior Q | FY 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $690M | — | $710M | — | -2.8% |
| Op. Income | $303M | — | $292M | — | 3.7% |
| Gross Margin | 74.3% | — | 69.8% | — | 4.5pp |
| Net Margin | 33.1% | — | 30.6% | — | 2.4pp |
| EPS (Diluted) | $4.92 | — | $4.29 | — | 14.7% |
| Free Cash Flow | $258M | — | $223M | — | 15.8% |
| Item | Amount |
|---|---|
| REVENUE | $690M |
| Cost of Revenue | $178M |
| GROSS PROFIT | $513M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $143M |
| SG&A Expenses | $143M |
| Other Expenses | $67M |
| Operating Expenses | $210M |
| Cost & Expenses | $387M |
| OPERATING INCOME | $303M |
| Interest Income | $551M |
| Interest Expense | $176M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $303M |
| Income Tax Expense | $75M |
| Net Income from Continuing Ops | $228M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $228M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $228M |
| D&A | $0 |
| EBIT | $303M |
| EBITDA | $303M |
| EPS | $5 |
| EPS Diluted | $5 |
| Item | Amount |
|---|---|
| REVENUE | $690M |
| Cost of Revenue | $178M |
| GROSS PROFIT | $513M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $143M |
| SG&A Expenses | $143M |
| Other Expenses | $67M |
| Operating Expenses | $210M |
| Cost & Expenses | $387M |
| OPERATING INCOME | $303M |
| Interest Income | $551M |
| Interest Expense | $176M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $303M |
| Income Tax Expense | $75M |
| Net Income from Continuing Ops | $228M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $228M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $228M |
| D&A | $0 |
| EBIT | $303M |
| EBITDA | $303M |
| EPS | $5 |
| EPS Diluted | $5 |
| Item | Amount |
|---|---|
| Net Income | $228M |
| Depreciation & Amortization | $0 |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | $13M |
| Change in Working Capital | $24M |
| OPERATING CASH FLOW | $265M |
| Capital Expenditure | -$7M |
| Acquisitions (Net) | $174.0K |
| Purchases of Investments | -$436M |
| Sales/Maturities of Investments | $315M |
| Other Investing Activities | -$936M |
| NET CASH FROM INVESTING | -$1.1B |
| Net Debt Issuance | $299M |
| Common Stock Repurchased | -$378M |
| Common Dividends Paid | $0 |
| Other Financing Activities | $419M |
| NET CASH FROM FINANCING | $342M |
| FREE CASH FLOW | $258M |
| Net Change in Cash | -$457M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $8M |
| Short-Term Investments | $1.7B |
| Net Receivables | $43M |
| Inventory | $0 |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $1.7B |
| PP&E (Net) | $0 |
| Goodwill | $0 |
| Intangible Assets | $0 |
| Long-Term Investments | $0 |
| Tax Assets | $0 |
| Other Non-Current Assets | $19M |
| TOTAL NON-CURRENT ASSETS | $19M |
| TOTAL ASSETS | $9.4B |
| Account Payables | $0 |
| Short-Term Debt | $199M |
| Deferred Revenue | $0 |
| Other Current Liabilities | $0 |
| TOTAL CURRENT LIABILITIES | $199M |
| Long-Term Debt | $223M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $8.2B |
| TOTAL NON-CURRENT LIABILITIES | $8.5B |
| TOTAL LIABILITIES | $8.7B |
| Common Stock | $690M |
| Additional Paid-In Capital | $0 |
| Retained Earnings | $0 |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $0 |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $690M |
| Minority Interest | $0 |
| TOTAL EQUITY | $690M |
| TOTAL LIABILITIES & EQUITY | $9.4B |
| Total Debt | $422M |
| Net Debt | $414M |
